Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NEW PRODUCT／Sanofi-aventis: Clexane Kit for SC Injection
May 19, 2008
- TOPICS／Mylan Accepted as JPMA Member
May 19, 2008
- Asahi Kasei Pharma: Sales Up 6.5% to \111.2 Bil.
May 19, 2008
- Nihon Chouzai Promotes Dispensing of Generics
May 19, 2008
- Bonalon Drives Teijin's Pharma Business
May 19, 2008
- OBITUARY／Dr Yutaka Mizushima: Former Chairman of LTT-Bio Pharma
May 19, 2008
- Kyowa Hakko: Sales Up 10.7% to \392 Bil.
May 19, 2008
- REGULATORY NEWS IN BRIEF
May 19, 2008
- Santen: Overseas Sales Account for 14.3% of Total Sales
May 19, 2008
- Prof. H. Endo Elected Chairman of Chuikyo
May 19, 2008
- MTPC: Remicade Continues Strong Growth
May 19, 2008
- JMA Has Not Yet Decided on Its Stance Regarding the FPMAJ's Pricing System Reform Proposal: Dr Takeshima
May 19, 2008
- Takeda: Heavy R&D Costs Cut Operating Profits
May 19, 2008
- Korosho to Consider Creating Japanese Version of FDA
May 19, 2008
- Pletaal Launched in Sweden: Otsuka
May 19, 2008
- Life Science Summit Calls For Creation of Japanese Version of FDA, NIH, OSCHR
May 19, 2008
- Bayer to Grow Twice as Fast as Market Aiming at \200 Bil. Sales: President J-L Lowinski
May 19, 2008
- Divergent Opinions on Japanese Version of FDA among LDP Members
May 19, 2008
- Daiichi Sankyo to Apply for Combination of Olmetec and Calblock
May 19, 2008
- Banyu's Isentress Roughly Recommended for Approval
May 19, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…